FIGS

FIGS INC

Consumer Cyclical | Mid Cap

$0.03

EPS Forecast

$161.8

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-08-29

FIGS, Inc. Q2 2026 Earnings: Tariff Windfalls, Margin Expansion, and a Recharged Outlook

NYSE: FIGS • EPS: $0.15 diluted • August 6, 2026

Executive snapshot: what FIGS just stitched together

FIGS, Inc. (NYSE: FIGS) reported a second quarter 2026 that reads like a case study in how a good quarter can hinge on a one-time tailwind and still leave room for longer-term growth. The company delivered net revenues of $196.6 million, up 28.8% year over year, with a split that shows scrubwear leading the charge and non-scrubwear re-accelerating. Diluted earnings per share were $0.15, up from a loss of a year ago and well above the 201-year baseline we might have guessed from prior quarters. The release emphasizes both top-line momentum and margin resilience, aided in part by tariff refunds and pricing efficiency. There is no EPS consensus or stated earnings surprise in the filing, but the reported EPS represents a meaningful improvement versus the prior-year period.

Key numbers and what they suggest

  • Total net revenues: $196.6 million, +28.8% YoY.
  • Scrubwear net revenues: $161.2 million, +26.5% YoY.
  • Non-scrubwear net revenues: $35.4 million, +40.3% YoY.
  • U.S. net revenues: $158.7 million, +22.2% YoY.
  • International net revenues: $37.9 million, +67.0% YoY.
  • Gross margin: 75.2%, up 820 basis points YoY, aided by tariff refunds and pricing/efficiency gains.
  • Operating expenses: $112.6 million, +21.9% YoY, with margin improvements as a result of fixed-cost leverage and lower stock-based compensation expense.
  • Net income: $28.4 million, or $0.15 per diluted share (vs. $7.1 million and $0.04 in the prior-year period).
  • Net income margin: 14.4% (vs. 4.7% year-ago).
  • Adjusted EBITDA margin: 18.6% (per the release, though the exact dollar figure isn’t reiterated in this fragment).

What moved the needle—and what didn’t

The headline margin story hinges on an unusual contributor: tariff refunds recognized under IEEPA. Those refunds boosted gross margin meaningfully, amplified by favorable pricing actions and ongoing efficiency efforts. The gain was partially offset by higher tariffs in other areas, and the company notes that fixed-cost leverage helped push operating margins lower relative to revenue growth. In lay terms: the quarter benefited from a one-time lift, but the business still showed discipline in its cost base as volumes rose.

On the expense side, operating costs rose in tandem with revenue, yet their impact as a share of net revenues declined—from 60.5% in the prior-year period to 57.3% this quarter—because the fixed-cost base was better leveraged. The combination of top-line strength and margin discipline produced a robust net income trajectory, culminating in a double-digit net income margin and a clean, positive EPS print.

Line-item highlights in the earnings narrative

The revenue mix continues to tilt toward scrubwear, with consistent growth in international markets showing late-stage acceleration (international net revenues up 67% YoY). Management also signaled strategic capital allocation through a $100 million increase to its share repurchase authorization, a classic move signaling confidence in cash generation and a desire to optimize the equity base.

Importantly, the company raised its full-year 2026 outlook alongside the quarterly results, signaling the durability of the revenue engine and the belief that the margin drivers observed this quarter can extend into the remainder of the year.

Outlook and what it portends for FIGS and peers

The raised revenue outlook reinforces the notion that FIGS’ growth trajectory remains intact despite a challenging macro backdrop for discretionary spending in some consumer-facing segments. The mix shift toward higher-growth categories and international expansion adds optionality to the model, while tariff-related tailwinds—though welcome—are not guaranteed to recur in the same magnitude.

From a sector perspective, the results create a compelling reference point for peers in healthcare apparel and related consumer-industrial niches. If FIGS can sustain gross margin expansion while growing revenue at a double-digit pace and boosting free cash flow, competitors may feel pressure to lift guidance or accelerate investments in pricing, product mix, and international channels.

On the earnings-translation front, the absence of a published EPS consensus or explicit earnings surprise in the release means investors should calibrate their expectations around quarterly volatility and one-time tailwinds. The reported EPS of $0.15 is a positive signal, but the magnitude of any future earnings surprise will hinge on whether tariff effects persist and how the company manages ongoing operating costs as volumes scale.

Takeaways and potential pitfalls

  • The tariff refunds provided a meaningful but potentially non-recurring lift to gross margin—watch for year-over-year comparables to normalize.
  • The revenue mix remains favorable to higher-margin segments, with international growth offering a structural upside despite potential cross-border volatility.
  • Stock buyback capacity is expanding, signaling confidence in cash generation and a desire to balance capital returns with growth investments.
  • EPS trajectory looks solid this quarter, but absent an EPS consensus, the earnings surprise narrative remains uncertain until subsequent results either validates or surprises the model.
  • Peer dynamics: if FIGS sustains its pace and raises the revenue forecast, sector peers may need to respond with conservative guidance or accelerated efficiency programs to maintain competitive positioning.

Conclusion: a quarter that stitches growth with margin prudence

FIGS’ Q2 2026 results present a coherent narrative: top-line momentum across a broadened product set, a margin story buoyed by one-time tariff benefits, and a disciplined approach to cost control. The company translates growth into earnings leverage and a refreshed capital-return plan, suggesting that the next several quarters could be well-positioned to test the durability of these dynamics. For FIGS and its peers, the takeaway is clear—translate strong quarterly cadence into a credible full-year revenue forecast, monitor the tariff tailwinds, and keep a close eye on whether international expansion can continue to compound margins without inviting margin-dilutive pressures from the cost side.